News
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Valneva SE (ISIN: FR0004056851) research, maintains Buy recommendation with lowered price target. Q1/26 sales declined by 37.2% to €30.9m. Market awaiting Pfizer's BLA submission for Lyme disease vaccine candidate LB6V -
-
-
-
-
-
-